4.6 Review

The psychological impact of rosacea and the influence of current management options

期刊

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2014.05.036

关键词

depression; dermatology; mental health; psychosocial; quality of life; rosacea; self-esteem; self-image

资金

  1. Galderma Laboratories LP

向作者/读者索取更多资源

Background: Rosacea is a common problem that is underdiagnosed; if left untreated can result in physical disfigurement and emotional distress. Objective: We reviewed the current literature to determine the degree of psychosocial impact of rosacea and the importance of treatment. We also reviewed the current treatment options. Methods: A search of the MEDLINE, EMBASE, and psycINFO databases from 1946 to present was performed to identify previous articles regarding the psychosocial and quality-of-life (QoL) impact of rosacea. Results: A total of 17 studies were found that focused on the following areas: impact of disease on QoL, improvement of QoL with treatment, and willingness to pay. Limitations: Reviewed articles used different measurement systems to quantify impact on QoL making comparisons between studies difficult to interpret. Conclusion: Patients with rosacea have higher incidences of embarrassment, social anxiety, depression, and decreased QoL compared with the rest of the population. Adequate treatment of symptoms results in improvement of QoL in patients with rosacea. New options that target the facial erythema of rosacea may help mitigate the negative psychological impact of rosacea.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis

Patrick O. Perche, Madison K. Cook, Steven R. Feldman

Summary: This article reviews the efficacy and safety of abrocitinib as an oral medication for patients with moderate-to-severe atopic dermatitis. The study found that abrocitinib is effective in treating atopic dermatitis, with higher efficacy compared to other conventional medications, and has fewer side effects.

ANNALS OF PHARMACOTHERAPY (2023)

Review Pharmacology & Pharmacy

Review of Calcipotriene and Betamethasone Dipropionate Cream in the Treatment of Psoriasis

Alexandra Taylor, Rohan Singh, Steven R. Feldman

Summary: This review highlights the pharmacokinetics, efficacy, and safety of recently approved calcipotriene and betamethasone dipropionate (C-BD) cream in the treatment of psoriasis. The results showed that C-BD cream was effective and safe, with higher treatment success rates compared to C-BD topical suspension and vehicle. The use of C-BD cream provides a convenient and preferred option for patients with mild-to-moderate psoriasis.

ANNALS OF PHARMACOTHERAPY (2023)

Review Pharmacology & Pharmacy

A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis

Jessica N. Pixley, Taylor Schaetzle, Steven R. Feldman

Summary: This article reviews clinical trials on the efficacy, safety, and clinical application of once-daily roflumilast 0.3% cream for plaque psoriasis treatment. The results show that roflumilast is effective and safe, and it has potential as a nonsteroidal alternative to topical corticosteroids.

ANNALS OF PHARMACOTHERAPY (2023)

Article Infectious Diseases

Prescribing Trends for Acne Vulgaris Visits in the United States

Patrick O. Perche, Gabrielle M. Peck, Lillian Robinson, Ayman Grada, Alan B. Fleischer Jr, Steven R. Feldman

Summary: Acne vulgaris is a common reason for patients to seek care from dermatologists in the US, but referring providers may be hesitant to prescribe acne treatments or certain medications. A study analyzed prescription rates for acne therapies from 1993 to 2016 and found that younger patients and privately insured patients were more likely to receive prescription treatments. Dermatologists were more likely to recommend prescription medications compared to family medicine and pediatric providers. Oral minocycline and oral doxycycline were the most commonly prescribed antibiotics, while benzoyl peroxide was the most utilized and recommended over-the-counter drug for acne.

ANTIBIOTICS-BASEL (2023)

Editorial Material Dermatology

Commentary on Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology

Heli Patel, Steven R. Feldman

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2023)

Review Pharmacology & Pharmacy

Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Christopher Alihosseini, Hannah Kopelman, Mallory Zaino, Steven R. Feldman

Summary: This study reviewed the safety and efficacy of avacopan for the treatment of ANCA-associated vasculitis. The results showed that avacopan can improve remission rates and reduce side effects caused by steroid use. Therefore, avacopan may be a new option for the treatment of ANCA-associated vasculitis.

ANNALS OF PHARMACOTHERAPY (2023)

Review Pharmacology & Pharmacy

A Review of Topical Tapinarof for the Treatment of Plaque Psoriasis

Meghan C. Grossmann, Jessica N. Pixley, Steven R. Feldman

Summary: This article reviews the efficacy and safety of 1% tapinarof cream for plaque psoriasis. The results of two 12-week phase III clinical trials showed that around 35.4% to 40.2% of patients achieved clear or almost clear disease severity at week 12. In the 40-week, open-label extension trial, 40.9% of patients achieved a Physician's Global Assessment (PGA) score of 0 at least once. Tapinarof may be an effective and safe topical treatment for mild to severe plaque psoriasis.

ANNALS OF PHARMACOTHERAPY (2023)

Letter Dermatology

Regional Variation in Cardiovascular Risk Factor Screening by Dermatologists for Psoriasis Patients in the United States

William B. Song, Gabrielle M. Peck, Aakriti Neopaney, Daniel B. Shin, Alan B. Fleischer Jr, Steven R. Feldman, Joel M. Gelfand, Hideki Mochizuki, James T. Elder, Yukinori Okada

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Letter Dermatology

Patients with vulvar lichen sclerosus prioritize education on disease etiology, triggers and treatment

Emily A. Parks, Mallory L. Zaino, Jessica N. Pixley, Vani Mangalam Subramanian, Deepak Sirdeshmukh, Steven R. Feldman, Rita O. Pichardo

JOURNAL OF DERMATOLOGICAL TREATMENT (2023)

Article Dermatology

Management of Pediatric Psoriasis: A US Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS)

Rachel E. Tao, Jessica N. Pixley, Phillip G. Holovach, Alan B. Fleischer Jr, Steven R. Feldman

Summary: Off-label treatments are commonly used for pediatric psoriasis, with topical treatments, especially unapproved tacrolimus, being the most common approach. This may indicate a hesitance to use corticosteroids in children.

DERMATOLOGY AND THERAPY (2023)

Review Infectious Diseases

Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy

Rachel E. Tao, Stuti Prajapati, Jessica N. Pixley, Ayman Grada, Steven R. Feldman

Summary: Tetracycline-class drugs are commonly used in dermatology for treating skin diseases. This study reviewed the available evidence on whether taking these drugs with food affects their absorption and clinical efficacy. The study found that co-administration with food decreased systemic absorption of tetracycline, while the impact on doxycycline and minocycline varied. Oral sarecycline showed decreased absorption with food. Only sarecycline demonstrated limited or no impact of food intake on clinical efficacy. The study suggested considering patient adherence when choosing to take doxycycline, minocycline, and sarecycline with food.

ANTIBIOTICS-BASEL (2023)

Review Pharmacology & Pharmacy

Noncorticosteroid Topical Therapies for the Treatment of Plaque Psoriasis: A Narrative Review

Rithi J. J. Chandy, Diem-Phuong D. Dao, Cristian C. C. Rivis, Divya M. M. Shan, Steven R. R. Feldman

Summary: The objective of this study was to compare the safety and efficacy of noncorticosteroid topical treatments for plaque psoriasis. A literature search was conducted, and relevant articles and clinical trial data were analyzed. Six classes of noncorticosteroid topicals were studied, and the results showed that they are effective and safe for treating plaque psoriasis.

JOURNAL OF PHARMACY TECHNOLOGY (2023)

Review Biochemistry & Molecular Biology

The Genetic Susceptibility to Psoriasis and the Relationship of Linked Genes to Our Treatment Options

Heli A. A. Patel, Rishab R. R. Revankar, Sofia T. T. Pedroza, Shaveonte Graham, Steven R. R. Feldman

Summary: Understanding the genetic factors in psoriasis can help improve targeted treatment strategies. This review discusses the genes associated with psoriasis pathogenesis and their connection to available treatment options. Searching various databases, relevant genetic markers and treatments were identified. Gene variants involved in inflammatory pathways, such as interleukins and interferons, are commonly implicated in psoriasis. Some treatments, like IL23 and TYK2 inhibitors, target genes associated with psoriasis. Multiple genes are involved in psoriasis pathogenesis, providing potential avenues for developing new treatment strategies and improving outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Dermatology

Understanding the Medical Dictionary for Regulatory Activities (MedDRA) reporting of herpes simplex virus (HSV) adverse events in atopic dermatitis clinical trials

Rachel E. Tao, Jessica N. Pixley, Christina L. Kontzias, Steven R. Feldman

Summary: Drug efficacy is best evaluated through randomized, controlled, double-blind clinical trials, while safety assessment is more challenging. The Medical Dictionary for Regulatory Activities (MedDRA) is used to track and categorize adverse events (AE) during clinical trials. This study reviewed recent clinical trials on atopic dermatitis to demonstrate the importance of understanding MedDRA in evaluating adverse events related to herpes simplex virus (HSV) infection.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2023)

Review Dermatology

Quality of Life Assessments Utilized in Vitiligo Clinical Trials

Gaurav N. Pathak, Rithi J. Chandy, Vidisha Naini, Steven R. Feldman, Babar K. Rao

Summary: This study analyzed clinical trials on vitiligo and found that less than half of the trials used quality of life (QoL) assessments, with DLQI and CDLQI being the commonly used tools. As the number of trials increases, vitiligo-specific questionnaires may be more suitable for evaluating unique vitiligo-related concerns.

DERMATOLOGIC THERAPY (2023)

暂无数据